Aconite poisoning following the percutaneous absorption of Aconitum alkaloids

被引:39
作者
Chan, Thomas Y. K. [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Div Clin Pharmacol, Dept Med & Therapeut,Fac Med, Shatin, Hong Kong, Peoples R China
关键词
Aconite poisoning; Aconite roots; Aconitum alkaloids; Aconite tincture; Percutaneous absorption;
D O I
10.1016/j.forsciint.2012.06.016
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
In vitro experiment using the modified Franz-type diffusion cell has demonstrated that the human skin is permeable to aconitine and mesaconitine. To characterise the risk of systemic toxicity following the topical applications of aconite tincture and raw aconite roots, relevant reports of percutaneous absorption of Aconitum alkaloids and aconite poisoning are reviewed. Published reports indicate that aconite tincture and raw aconite roots can be absorbed through the skin into systemic circulation to cause fatal and non-fatal aconite poisoning. Both aconite tincture and raw aconite roots contain very high concentrations of Aconitum alkaloids, which allow penetration of the stratum corneum along the diffusion gradient. The risk of systemic toxicity is even higher if Aconitum alkaloids are held in occlusive contact with the skin and the epidermis (stratum corneum) is already damaged. The public should be warned of the danger in using these topical aconite preparations and the risk of systemic toxicity following percutaneous absorption of Aconitum alkaloids. (c) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:25 / 27
页数:3
相关论文
共 19 条
  • [11] Shao S.M., 2004, J SICHUAN CONTIN ED, V23, P113
  • [12] Delivering drugs by the transdermal route: review and comment
    Tanner, T.
    Marks, R.
    [J]. SKIN RESEARCH AND TECHNOLOGY, 2008, 14 (03) : 249 - 260
  • [13] Overcoming the stratum corneum: The modulation of skin penetration - A review
    Trommer, H.
    Neubert, R. H. H.
    [J]. SKIN PHARMACOLOGY AND PHYSIOLOGY, 2006, 19 (02) : 106 - 121
  • [14] Yan F.P., 2009, CHIN J FORENSIC SCI, V6, P87
  • [15] Yao X.Q., 1999, J TRADIT CHIN MED, V30, P15
  • [16] Yu C.C., 2000, J MIANYANG NORMAL U, V28, P51
  • [17] Yu C.C., 2000, J MIANYANG NORMAL U, V28, P59
  • [18] Zhao P, 2007, J HARBIN U COMMERCE, V23, P663
  • [19] Zhou J.H., 2001, AGR RECLAMATION MED, V3, P192